Mark A. Velleca - Net Worth and Insider Trading
Mark A. Velleca Net Worth
The estimated net worth of Mark A. Velleca is at least $829,400 dollars as of 2024-11-10. Mark A. Velleca is the Director of G1 Therapeutics Inc and owns about 116,000 shares of G1 Therapeutics Inc (GTHX) stock worth over $829,400. Details can be seen in Mark A. Velleca's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark A. Velleca has not made any transactions after 2023-08-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark A. Velleca
Mark A. Velleca Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark A. Velleca owns 2 companies in total, including G1 Therapeutics Inc (GTHX) , and Black Diamond Therapeutics Inc (BDTX) .
Click here to see the complete history of Mark A. Velleca’s form 4 insider trades.
Insider Ownership Summary of Mark A. Velleca
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2023-08-08 | director & President and CEO |
| BDTX | Black Diamond Therapeutics Inc | 2021-08-09 | director |
Mark A. Velleca Latest Holdings Summary
Mark A. Velleca currently owns a total of 1 stock. Mark A. Velleca owns 116,000 shares of G1 Therapeutics Inc (GTHX) as of August 8, 2023, with a value of $829,400.
Latest Holdings of Mark A. Velleca
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2023-08-08 | 116,000 | 7.15 | 829,400 |
Holding Weightings of Mark A. Velleca
Mark A. Velleca Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark A. Velleca has made a total of 11 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in G1 Therapeutics Inc is the sale of 60,000 shares on August 8, 2023, which brought Mark A. Velleca around $120,000.
Insider Trading History of Mark A. Velleca
- 1
Mark A. Velleca Trading Performance
Mark A. Velleca Ownership Network
Ownership Network List of Mark A. Velleca
Ownership Network Relation of Mark A. Velleca
Mark A. Velleca Owned Company Details
What does G1 Therapeutics Inc do?
Who are the key executives at G1 Therapeutics Inc?
Mark A. Velleca is the director & President and CEO of G1 Therapeutics Inc. Other key executives at G1 Therapeutics Inc include Chief Financial Officer John V. Umstead , Chief Commercial Officer Andrew Perry , and Chief Business Officer Mark Avagliano .
G1 Therapeutics Inc (GTHX) Insider Trades Summary
Over the past 18 months, Mark A. Velleca made 1 insider transaction in G1 Therapeutics Inc (GTHX) with a net sale of 60,000. Other recent insider transactions involving G1 Therapeutics Inc (GTHX) include a net sale of 78,166 shares made by Rajesh Malik , a net sale of 92,308 shares made by Bailey John E. (jack) Jr. , and a net sale of 15,968 shares made by John V. Umstead .
In summary, during the past 3 months, insiders sold 0 shares of G1 Therapeutics Inc (GTHX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 295,121 shares of G1 Therapeutics Inc (GTHX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 295,121 shares.
G1 Therapeutics Inc (GTHX)'s detailed insider trading history can be found in Insider Trading Tracker table.
G1 Therapeutics Inc Insider Transactions
Mark A. Velleca Mailing Address
Above is the net worth, insider trading, and ownership report for Mark A. Velleca. You might contact Mark A. Velleca via mailing address: 79 Tw Alexander Drive, 4501 Research Commons, Suite 100, Research Triangle Park Nc 27709.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
